BMY – Bristol-Myers Squibb Company 百时美施贵宝

百时美施贵宝公司 (Bristol-Myers Squibb Company) 于1933年8月根据特拉华州法律注册成立,名为百时美公司,继承了1887年在纽约成立的一家企业。1989年,由于合并,公司更名为百时美施贵宝公司。公司在全球范围内从事生物制药产品的发现、开发、许可、制造、营销、分销和销售。

中文介绍: https://xueqiu.com/S/BMY

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.

英文介绍: https://www.morningstar.com/stocks/xnys/bmy/quote

主题测试文章,只做测试使用。发布者:star,转转请注明出处:http://wallstreetgm.com/bmy-bristol-myers-squibb-company-%e7%99%be%e6%97%b6%e7%be%8e%e6%96%bd%e8%b4%b5%e5%ae%9d/

发表评论

您的电子邮箱地址不会被公开。 必填项已用*标注